Stocks · News reference

BillionToOne shares are trading lower after the company reported mixed Q3 financial results.

Aug 5, 2026, 8:45 PMBenzinga Newsdesk

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 5, 2026, 8:45 PM
Checked: Aug 5, 2026, 8:45 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaOct 7, 2026, 11:05 AMBenzinga Newsdesk
BillionToOne Says Northstar Response Cancer Blood Test Agrees With Tissue-Based Assay In 94% Of Cases In 61-Patient Retrospective Study
BLLN
BenzingaOct 1, 2026, 2:09 PMBenzinga Newsdesk
Guggenheim Maintains Buy on BillionToOne, Raises Price Target to $128
BLLN
BenzingaSep 23, 2026, 6:09 PMVandana Singh
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
BLLN CDNA
BenzingaSep 2, 2026, 3:42 PMBenzinga Newsdesk
Canaccord Genuity Initiates Coverage On BillionToOne with Buy Rating, Announces Price Target of $120
BLLN